Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) SHZ

23.47

-0.46(-1.92%)

Updated at June 03 09:36AM

Currency In CNY

Valuation

Market Cap13.28B
Enterprise Value13.24B
P/E Ratio-136.34
PEG Ratio-9.35
Price/Sales Ratio56.07
Price/Book Ratio14.12
Enterprise/Revenue56.03
Enterprise/EBITDA-178.82

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.41
Operating Margin-0.44

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.09

Income Statement

Revenue220.23M
Revenue/Share0.43
Gross Profit170.15M
EBITDA-55.69M
Net Income-77.76M
Diluted EPS-0.16

Balance Sheet

Total Cash128.28M
Total Cash/Share0.27
Total Debt119.78M
Total Debt/Equity0.15
Current Ratio2
Book Value Per Share1.66

Price History

52-Week Change-24.75
52-Week High66.66
52-Week Low22.44
Moving Average 50 Days27.9
Moving Average 200 Days31.04

Statistics

Average Volume31.88M
Shares Outstanding477.77M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor1399:1000
Last Split DateMay 05, 2016